Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice

Journal of Clinical Oncology

Volumn , Issue 26, 2014, Pages 2847-2854

  Timmerman, Robert D ^a   Herman, Joseph ^b   Cho, L Chinsoo ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DISEASE MODEL; FIBROSIS; HUMAN; INTESTINE; LOCAL THERAPY; MEDICAL TECHNOLOGY; METASTASIS; NECROSIS; NERVOUS TISSUE; OUTPATIENT CARE; PATIENT SELECTION; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY; REVIEW; STENOSIS; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER; CANCER MODEL; DISEASE ERADICATION; DNA DAMAGE; LIVER TUMOR; LUNG TUMOR; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TARGET ORGAN; THERAPY EFFECT; NEOPLASMS; PROCEDURES; RADIOSURGERY; TRENDS;

HUMANS; NEOPLASMS; RADIOSURGERY;

EID: 84907016506     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.4675     Document Type: Review

References (63)

1. Papiez L, Timmerman R, DesRosiers C, et al: Extracranial stereotactic radioablation: Physical principles. Acta Oncol 42:882-894, 2003
2. Timmerman R, Papiez L, McGarry R, et al: Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I nonsmall cell lung cancer. Chest 124:1946-1955, 2003
3. Potters L, Steinberg M, Rose C, et al: American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 60: 1026-1032, 2004
4. Loo BW Jr, Chang JY, Dawson LA, et al: Stereotactic ablative radiotherapy: Whats in a name? Pract Radiat Oncol 1:38-39, 2011
5. Timmerman RD, Kavanagh BD, Cho LC, et al: Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25:947-952, 2007
6. Fletcher GH: Hypofractionation: Lessons from complications. Radiother Oncol 20:10-15, 1991
7. Rosenthal DI, Glatstein E: Weve got a treatment, but whats the disease? Or a brief history of hypofractionation and its relationship to stereotactic radiosurgery. Oncologist 1:1-7, 1996
8. Cox JD: Large-dose fractionation (hypofractionation). Cancer 55:2105-2111, 1985 (suppl 9)
9. Kolesnick R, Fuks Z: Radiation and ceramideinduced apoptosis. Oncogene 22:5897-5906, 2003
10. Yuan S, Sun X, Li M, et al: A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30:239-244, 2007
11. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, et al: Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 83:348-353, 2012
12. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75:677-682, 2009
13. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006
14. Hof H, Herfarth KK, Mü nter M, et al: Stereotactic single-dose radiotherapy of stage I non-smallcell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:335-341, 2003
15. Whyte RI, Crownover R, Murphy MJ, et al: Stereotactic radiosurgery for lung tumors: Preliminary report of a phase I trial. Ann Thorac Surg 75:1097-1101, 2003
16. McGarry RC, Papiez L, Williams M, et al: Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63:1010-1015, 2005
17. Nagata Y, Takayama K, Matsuo Y, et al: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427-1431, 2005
18. Le QT, Loo BW, Ho A, et al: Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 1:802-809, 2006
19. Rusthoven KE, Kavanagh BD, Burri SH, et al: Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27:1579-1584, 2009
20. Kavanagh BD, Schefter TE, Cardenes HR, et al: Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45:848-855, 2006
21. Baumann P, Nyman J, Hoyer M, et al: Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer: A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 88:359-367, 2008
22. Rule W, Timmerman R, Tong L, et al: Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 18:1081-1087, 2011
23. Palma DA, Haasbeek CJ, Rodrigues GB, et al: Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABRCOMET): Study protocol for a randomized phase II trial. BMC Cancer 12:305, 2012
24. Herfarth KK, Debus J, Lohr F, et al: Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 19:164-170, 2001
25. Koong AC, Le QT, Ho A, et al: Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58:1017-1021, 2004
26. Goodman KA, Wiegner EA, Maturen KE, et al: Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78:486-493, 2010
27. Stinauer MA, Kavanagh BD, Schefter TE, et al: Stereotactic body radiation therapy for melanoma and renal cell carcinoma: of single fraction equivalent dose on local control. Radiat Oncol 6:34, 2011
28. Herfarth KK, Debus J, Wannenmacher M: Stereotactic radiation therapy of liver metastases: Update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100-105, 2004
29. Rusthoven KE, Kavanagh BD, Cardenes H, et al: Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27:1572-1578, 2009
30. Lee MT, Kim JJ, Dinniwell R, et al: Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27:1585-1591, 2009
31. Wolbarst AB, Chin LM, Svensson GK: Optimization of radiation therapy: Integral-response of a model biological system. Int J Radiat Oncol Biol Phys 8:1761-1769, 1982
32. Baumann P, Nyman J, Hoyer M, et al: Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290-3296, 2009
33. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al: Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70:685-692, 2008
34. Timmerman R, Paulus R, Galvin J, et al: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070-1076, 2010
35. Armstrong JG, Minsky BD: Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 16:247-255, 1989
36. Kaskowitz L, Graham MV, Emami B, et al: Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27:517- 523, 1993
37. Dosoretz DE, Katin MJ, Blitzer PH, et al: Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol 6:98-104, 1996
38. Fisher B, Bauer M, Margolese R, et al: Fiveyear results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985
39. Chang DT, Swaminath A, Kozak M, et al: Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis. Cancer 117:4060- 4069, 2011
40. Katz AW, Carey-Sampson M, Muhs AG, et al: Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67:793-798, 2007
41. Hoyer M, Roed H, Traberg Hansen A, et al: Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45:823-830, 2006
42. Schefter TE, Kavanagh BD, Timmerman RD, et al: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371-1378, 2005
43. Blomgren H, Lax I, Näslund I, et al: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: Clinical experience of the first thirty-one patients. Acta Oncol 34:861- 870, 1995
44. Madsen BL, Hsi RA, Pham HT, et al: Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results. Int J Radiat Oncol Biol Phys 67:1099-1105, 2007
45. King CR, Freeman D, Kaplan I, et al: Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 109:217-221, 2013
46. Katz AJ, Santoro M, Diblasio F, et al: Stereotactic body radiotherapy for localized prostate cancer: Disease control and quality of life at 6 years. Radiat Oncol 8:118, 2013
47. Hodges JC, Lotan Y, Boike TP, et al: Costeffectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: An emerging initial radiation treatment option for organ-confined prostate cancer. J Oncol Pract 8:e31s-e37s, 2012 (suppl 3)
48. Parthan A, Pruttivarasin N, Davies D, et al: Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer. Front Oncol 2:81, 2012
49. Boike TP, Lotan Y, Cho LC, et al: Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol 29:2020-2026, 2011
50. Huguet F, Andre T, Hammel P, et al: Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25:326-331, 2007
51. Loehrer PJ Sr, Feng Y, Cardenes H, et al: Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial. J Clin Oncol 29:4105-4112, 2011
52. Conroy T, Gavoille C, Samalin E, et al: The role of the FOLFIRINOX regimen for advanced pancreatic cancer. Curr Oncol Rep 15:182-189, 2013
53. Gurka MK, Collins SP, Slack R, et al: Stereotactic body radiation therapy with concurrent fulldose gemcitabine for locally advanced pancreatic cancer: A pilot trial demonstrating safety. Radiat Oncol 8:44, 2013
54. Mahadevan A, Jain S, Goldstein M, et al: Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 78:735-742, 2010
55. Tozzi A, Comito T, Alongi F, et al: SBRT in unresectable advanced pancreatic cancer: Preliminary results of a mono-institutional experience. Radiat Oncol 8:148, 2013
56. Von Hoff DD, Ramanathan RK, Borad MJ, et al: Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial. J Clin Oncol 29:4548- 4554, 2011
57. Pan H, Simpson DR, Mell LK, et al: A survey of stereotactic body radiotherapy use in the United States. Cancer 117:4566-4572, 2011
58. Shikama N, Tsujino K, Nakamura K, et al: Survey of advanced radiation technologies used at designated cancer care hospitals in Japan. Jpn J Clin Oncol 44:72-77, 2014
59. Bondiau PY, Bahadoran P, Lallement M, et al: Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys 75:1041-1047, 2009
60. Rusthoven KE, Hammerman SF, Kavanagh BD, et al: Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol 48:578-583, 2009
61. Ollila DW, Caudle AS: Surgical management of distant metastases. Surg Oncol Clin N Am 15: 385-398, 2006
62. Rees M, Tekkis PP, Welsh FK, et al: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg 247:125-135, 2008
63. Timmerman RD, Bizekis CS, Pass HI, et al: Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 59:145-170, 2009